PRISMDIRECT
DEAD

Serial Number

98305240

Owner

SCIPHER MEDICINE CORPORATION

Attorney

Alyssa M. Worsham

First Use Date

Sep 13, 2021

Filing Date

Dec 8, 2023

Add to watchlist:

No watchlists yet
View on USPTO

PRISMDIRECT Trademark

Serial Number: 98305240

PRISMDIRECT is a trademark filed by SCIPHER MEDICINE CORPORATION on December 8, 2023. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

SCIPHER MEDICINE CORPORATION (7 trademarks)

500 Totten Pond Road, 6th Floor
Waltham, MA 02451

Entity Type: 03

Trademark Details

Filing Date

December 8, 2023

Registration Date

Not Registered

First Use Anywhere

September 13, 2021

First Use in Commerce

September 13, 2021

Goods & Services

Providing collected and analyzed medical information in the field of autoimmune diseases and treatment information for complex diseases and disorders for diagnostic and treatment purposes; providing medical data and information to pharmaceutical companies and healthcare providers; medical screening information services featuring alerts to pharmaceutical companies related to healthcare providers ordering medical diagnostic testing for patients; providing healthcare information and medical diagnostic services in the field of precision medicine, personalized medicine, and autoimmune disease; providing information in the fields of autoimmune diseases and pharmaceuticals

Data mining services in the field of precision medicine, personalized medicine and genomic sequencing; providing an AI-based data analytics platform in the field of precision medicine, personalized medicine, genomic sequencing and autoimmune diseases; software as a service (SAAS) featuring AI-based software for patient analytics in the field of precision medicine, personalized medicine, and autoimmune diseases; platform as a service (PAAS) featuring AI-based software for data analytics related to non-TNFi responder patients; platform as a service (PAAS) featuring AI-based software for use in providing data analytics and data insights; technology driven research, consultation, and platform services, namely consulting and providing PAAS featuring AI-based software in the field of precision medicine, personalized medicine and autoimmune diseases; diagnostic laboratory services in the field of precision medicine; scientific research in the field of disease modeling and precision medicine

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Jan 29, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jan 29, 2025 ABN2
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Oct 11, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Oct 11, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 15, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jul 15, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jul 15, 2024 CNRT
ASSIGNED TO EXAMINER
Jul 9, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 7, 2024 NWOS
NEW APPLICATION ENTERED
Dec 8, 2023 NWAP